Skip to content

Clinical Trial Testing Buzzy Bee vs Vapocoolant During IV Placement

A Randomized Clinical Trial of Buzzy Versus Vapocoolant in Pain Relief During Phlebotomy and IV Catheterization in the Pediatric ED

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06182631
Enrollment
172
Registered
2023-12-27
Start date
2019-07-15
Completion date
2021-01-15
Last updated
2025-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intravenous Administration

Keywords

analgesic, anxiolytic, Buzzy Bee, Shot-blocker

Brief summary

The purpose of this study is to compare the anxiety and pain levels of patients when using Buzzy with ice, Vapocoolant, and placebo when inserting IV's line for IV fluids and/or phlebotomy in pediatric patients in the pediatric emergency department.

Interventions

DEVICEBuzzy Bee

The Buzzy is a vibrating palm-sized device with removable ice wings developed by MMJ Labs Atlanta, GA. It uses Melzack and Wall's Gait Control theorywhich asserts that activation of non-nociceptive fibers can interfere with signals from pain fibers thereby inhibiting pain.

DRUGVapocoolent

Vapocoolent is a volatile refrigerated liquid, ie ethyl chloride, which is supposed to feel like the skin is numb before insertion of the IV.

OTHERPlacebo

A band will be placed on the arm before IV insertion for placebo effect.

Sponsors

State University of New York at Buffalo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Need IV's line placement for IV fluids and/or phlebotomy

Exclusion criteria

* patients sensitive to cold i.e. Raynaud's * critically ill patients * mentally challenged patients * GCS\< 15 * Patient with altered sensation * Patients needing more than one attempt at IV placement

Design outcomes

Primary

MeasureTime frameDescription
Pain Score Based on Wong-Baker Pain Scale During IV Placement With Buzzy Bee or Vapocoolentpost interventionWong- Baker Faces Pain Scale with scores: scale is 0-10, with 0 being no pain and 10 maximum pain. The changes in pain between the treatment groups were analyzed using chi square and one-way ANOVA for categorical and continuous variables respectively. Pre and post FACES pain scale-revised were reported as means and standard deviations
Perceived FACES Pain Score in Sensation of Pain During IV by Parent or Care-giverpost interventionFaces Pain Scale revised with scores: scale is 0-10, with 0 being no pain and 10 maximum pain.

Countries

United States

Participant flow

Recruitment details

221 Patients were approached by research assistants in the Emergency Department, 37 refused consent and 5 excluded due to medical reasons

Pre-assignment details

7 patients were then excluded due to multiple IV attempts

Participants by arm

ArmCount
Vapocoolant
Will have nurse spray vapocoolant on the skin before IV insertion, will then videotape patient and ask them and parent to fill out FACES form. Vapocoolent: Vapocoolent is a volatile refrigerated liquid, ie ethyl chloride, which is supposed to feel like the skin is numb before insertion of the IV.
57
Buzzy Bee
Will have nurse put Buzzy Bee on arm before, and leave it on during IV insertion. Will then videotape patient and ask them and parent to fill out FACES form. Buzzy Bee: The Buzzy is a vibrating palm-sized device with removable ice wings developed by MMJ Labs Atlanta, GA. It uses Melzack and Wall's Gait Control theorywhich asserts that activation of non-nociceptive fibers can interfere with signals from pain fibers thereby inhibiting pain.
56
Placebo
Will have nurse place a rubber band around arm before IV insertion. Will then videotape patient and ask them and parent to fill out FACES form. Placebo: A band will be placed on the arm before IV insertion for placebo effect.
58
Total171

Baseline characteristics

CharacteristicTotalBuzzy BeePlaceboVapocoolant
Age, Categorical
<=18 years
171 Participants56 Participants58 Participants57 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants0 Participants
Age, Continuous12.6 years
STANDARD_DEVIATION 3.9
12.6 years
STANDARD_DEVIATION 3.8
12.7 years
STANDARD_DEVIATION 4
12.4 years
STANDARD_DEVIATION 4.1
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants0 Participants1 Participants0 Participants
Race (NIH/OMB)
Asian
4 Participants2 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
23 Participants11 Participants5 Participants7 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
12 Participants6 Participants2 Participants4 Participants
Race (NIH/OMB)
White
131 Participants37 Participants49 Participants45 Participants
Region of Enrollment
United States
171 participants56 participants58 participants57 participants
Sex: Female, Male
Female
98 Participants27 Participants38 Participants33 Participants
Sex: Female, Male
Male
73 Participants29 Participants20 Participants24 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 570 / 560 / 58
other
Total, other adverse events
0 / 570 / 560 / 58
serious
Total, serious adverse events
0 / 570 / 560 / 58

Outcome results

Primary

Pain Score Based on Wong-Baker Pain Scale During IV Placement With Buzzy Bee or Vapocoolent

Wong- Baker Faces Pain Scale with scores: scale is 0-10, with 0 being no pain and 10 maximum pain. The changes in pain between the treatment groups were analyzed using chi square and one-way ANOVA for categorical and continuous variables respectively. Pre and post FACES pain scale-revised were reported as means and standard deviations

Time frame: post intervention

ArmMeasureGroupValue (MEAN)Dispersion
VapocoolantPain Score Based on Wong-Baker Pain Scale During IV Placement With Buzzy Bee or VapocoolentPre-intervention4.54 units on a scaleStandard Deviation 2.65
VapocoolantPain Score Based on Wong-Baker Pain Scale During IV Placement With Buzzy Bee or VapocoolentPost-intervention3.84 units on a scaleStandard Deviation 3.12
Buzzy BeePain Score Based on Wong-Baker Pain Scale During IV Placement With Buzzy Bee or VapocoolentPre-intervention5.41 units on a scaleStandard Deviation 2.9
Buzzy BeePain Score Based on Wong-Baker Pain Scale During IV Placement With Buzzy Bee or VapocoolentPost-intervention3.58 units on a scaleStandard Deviation 2.87
PlaceboPain Score Based on Wong-Baker Pain Scale During IV Placement With Buzzy Bee or VapocoolentPre-intervention5.03 units on a scaleStandard Deviation 3.01
PlaceboPain Score Based on Wong-Baker Pain Scale During IV Placement With Buzzy Bee or VapocoolentPost-intervention4.57 units on a scaleStandard Deviation 3.43
Primary

Perceived FACES Pain Score in Sensation of Pain During IV by Parent or Care-giver

Faces Pain Scale revised with scores: scale is 0-10, with 0 being no pain and 10 maximum pain.

Time frame: post intervention

ArmMeasureGroupValue (MEAN)Dispersion
VapocoolantPerceived FACES Pain Score in Sensation of Pain During IV by Parent or Care-giverPre-intervention3.06 units on a scaleStandard Deviation 2.98
VapocoolantPerceived FACES Pain Score in Sensation of Pain During IV by Parent or Care-giverPost-intervention2.24 units on a scaleStandard Deviation 2.56
Buzzy BeePerceived FACES Pain Score in Sensation of Pain During IV by Parent or Care-giverPre-intervention3.46 units on a scaleStandard Deviation 2.88
Buzzy BeePerceived FACES Pain Score in Sensation of Pain During IV by Parent or Care-giverPost-intervention1.69 units on a scaleStandard Deviation 2.28
PlaceboPerceived FACES Pain Score in Sensation of Pain During IV by Parent or Care-giverPre-intervention2.86 units on a scaleStandard Deviation 2.85
PlaceboPerceived FACES Pain Score in Sensation of Pain During IV by Parent or Care-giverPost-intervention2.79 units on a scaleStandard Deviation 2.84

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026